Clik here to view.
Is the Time Right to Invest in Biotech? Soros Thinks So
George Soros certainly thinks so. In a 3rd quarter 13-F filing for Soros Fund Management, the noted hedge fund manager initated two new biotech positions, immediately placing them into his top 10...
View ArticleHealthcare Sector Recap: Eli Lily, Bristol-Myers Squibb, and Pfizer React to...
Eli Lily and Company (NYSE:LLY), Bristol-Myers Squibb (NYSE:BMY), and Pfizer Inc. (NYSE:PFE) are the companies being affected most negatively by the 2012 outlook from Fitch and patent expirations for...
View ArticleHealthcare Business: GlaxoSmithKline Sells 17 Brands to Prestige, Depomed...
ImmunoGen (NASDAQ:IMGN) announces Eli Lilly (NYSE:LLY) will pay an upfront fee of $20 million and royalty payments that could sum up to $200 million for licenses. Using ImmunoGen’s (NASDAQ:IMGN)...
View ArticleHealthcare Biz Review: Salix Pharmaceuticals Plunges, Amyris Sees Negative...
NeurogesX’s (NASDAQ:NGSX) Qutenza patch was not recommended by the Food and Drug Administration for the treatment for nerve pain related to HIV-associated peripheral neuropathy. Investing Insights:...
View ArticleMarket Wrap: Groupon GRILLED, Shaw Group SPIKES, Oil REBOUNDS
Markets closed down on Wall Street today: Dow -0.02%, S&P -0.05%, Nasdaq -0.41%, Oil –0.63%, Gold +0.17%. On the commodities front, Oil (NYSE:USO) declined to $89.50 a barrel. Precious metals...
View ArticleSalix Pharmaceuticals Earnings Preview: Can This Streak Continue?
Salix Pharmaceuticals (NASDAQ:SLXP) will report earnings after markets close on Thursday, May 9th. Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the...
View ArticleSalix Pharmaceuticals Ltd. Earnings Call Insights: Fulyzaq and Apriso
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) recently reported its first quarter earnings and discussed the following topics in its earnings conference call. Fulyzaq Ami Fadia – UBS: I have got three...
View ArticleClik here to view.
3 Merger and Acquisitions Stock Stories For Due Diligence
Nuance Communications (NASDAQ:NUAN): Current price $19.61 On Thursday, Nuance announced that it will acquire the Tweddle Connect business, which is an application and content service delivery platform...
View ArticleClik here to view.
7 Stocks Making Big M&A News and Rumors This Week
Here’s your Cheat Sheet to this week’s top mergers and acquisition news: Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now! AstraZeneca Group...
View ArticleClik here to view.
BofA Executive Nominated for Under Secretary Of Commerce and 2 Other Hot...
Bank of America Corp. (NYSE:BAC): Current price $14.19 In a statement issued late on Thursday, it was announced that Bank of America Executive Vice Chair, Global Corporate and Investment Banking,...
View Article
